Reports of sudden onset of sleep (w/ or w/o warning signs); orthostatic hypotension; neuroleptic malignant syndrome; behavioural changes, hallucinations, confusion. Caution in patients w/ severe CV disease. Perform ophthalmological monitoring for retinal pathologic changes in people who suffer from albinismus oculi. Cases of retroperitoneal fibrosis, pulmonary infiltrates, pleural effusion, pleural thickening, pericarditis, & cardiac valvulopathy in some patients treated w/ ergot-derived dopaminergic agents. May potentiate dopaminergic side effects of levodopa & cause or exacerbate pre-existing dyskinesia. Frequently monitor patients for melanomas during treatment. Discontinue treatment over a period of 1 wk. May impair ability to drive or use machines. Patient w/ renal impairment. Pregnancy. Do not administer to women who wish to breast-feed infants. Not recommended in ped patients. Elderly >65 yr.
Sign Out
